Multiplex Detection Immunoassay Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Description
Persistence Market Research has recently published an in-depth report on the global Multiplex Detection Immunoassay Market, offering a detailed analysis of key market trends, growth dynamics, opportunities, and challenges. This report provides strategic insights for stakeholders aiming to capitalize on the evolving landscape of multiplex diagnostics and drive business growth through informed decisions.
Key Insights:
The multiplex detection immunoassay market covers technologies that enable simultaneous detection of multiple analytes in a single test, significantly improving diagnostic speed and accuracy. These assays are widely used in disease diagnostics, drug development, and biomedical research. The increasing demand for precision medicine, along with growing cases of chronic and infectious diseases, is driving the adoption of multiplex immunoassays. Their ability to save time and reduce sample volume makes them an essential tool in modern laboratories and clinical settings.
Market Growth Drivers:
The growth of the global multiplex detection immunoassay market is propelled by a rising need for efficient, high-throughput diagnostic solutions. The growing burden of diseases like cancer, cardiovascular disorders, and infectious outbreaks has created a strong demand for rapid and reliable testing methods. Multiplex assays enable simultaneous testing for multiple biomarkers, reducing diagnostic time and cost. Furthermore, increased investments in life sciences research, expanding applications in drug discovery, and government funding in healthcare R&D are accelerating market growth. The surge in personalized medicine is also enhancing demand for multiplex platforms.
Market Restraints:
Despite notable advantages, the market faces a few constraints that could hinder its growth trajectory. High setup and operational costs associated with advanced multiplex platforms can be a barrier, especially in low-resource settings. Technical challenges such as assay interference, standardization difficulties, and the need for skilled personnel limit widespread adoption. In addition, navigating complex regulatory environments for assay validation and commercialization remains a significant hurdle for both new entrants and established players in the field.
Market Opportunities:
The multiplex detection immunoassay market presents multiple avenues for future growth. Advancements in microfluidics, nanotechnology, and automation are creating new possibilities for more accurate and scalable multiplex testing systems. Growing demand in emerging economies, driven by improving healthcare infrastructure and increased awareness of early disease detection, offers substantial market potential. Expansion of multiplex assays into point-of-care testing and integration with digital health platforms can further broaden their applications. Strategic collaborations, mergers, and investment in R&D are key to unlocking these opportunities and strengthening market competitiveness.
Key Questions Answered in the Report:
Leading companies in this market, such as Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, and Merck KGaA, are focusing on technological innovation and strategic partnerships to enhance product offerings. These firms are developing next-generation multiplex platforms with improved sensitivity and throughput. Collaborations with pharmaceutical companies and CROs are helping integrate multiplex assays into clinical trials and precision medicine programs. Moreover, companies are expanding into emerging markets and investing in digital tools for data interpretation to improve diagnostic workflows and gain a competitive edge.
Companies Covered in This Report:
By Product:
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- Multiplex Detection Immunoassay Market Size (2025E): US$ 3.2 Bn
- Projected Market Value (2032F): US$ 4.4 Bn
- Global Market Growth Rate (CAGR 2025 to 2032): 4.4%
The multiplex detection immunoassay market covers technologies that enable simultaneous detection of multiple analytes in a single test, significantly improving diagnostic speed and accuracy. These assays are widely used in disease diagnostics, drug development, and biomedical research. The increasing demand for precision medicine, along with growing cases of chronic and infectious diseases, is driving the adoption of multiplex immunoassays. Their ability to save time and reduce sample volume makes them an essential tool in modern laboratories and clinical settings.
Market Growth Drivers:
The growth of the global multiplex detection immunoassay market is propelled by a rising need for efficient, high-throughput diagnostic solutions. The growing burden of diseases like cancer, cardiovascular disorders, and infectious outbreaks has created a strong demand for rapid and reliable testing methods. Multiplex assays enable simultaneous testing for multiple biomarkers, reducing diagnostic time and cost. Furthermore, increased investments in life sciences research, expanding applications in drug discovery, and government funding in healthcare R&D are accelerating market growth. The surge in personalized medicine is also enhancing demand for multiplex platforms.
Market Restraints:
Despite notable advantages, the market faces a few constraints that could hinder its growth trajectory. High setup and operational costs associated with advanced multiplex platforms can be a barrier, especially in low-resource settings. Technical challenges such as assay interference, standardization difficulties, and the need for skilled personnel limit widespread adoption. In addition, navigating complex regulatory environments for assay validation and commercialization remains a significant hurdle for both new entrants and established players in the field.
Market Opportunities:
The multiplex detection immunoassay market presents multiple avenues for future growth. Advancements in microfluidics, nanotechnology, and automation are creating new possibilities for more accurate and scalable multiplex testing systems. Growing demand in emerging economies, driven by improving healthcare infrastructure and increased awareness of early disease detection, offers substantial market potential. Expansion of multiplex assays into point-of-care testing and integration with digital health platforms can further broaden their applications. Strategic collaborations, mergers, and investment in R&D are key to unlocking these opportunities and strengthening market competitiveness.
Key Questions Answered in the Report:
- What factors are driving the global multiplex detection immunoassay market?
- Which technology and end-use segments are expected to see the most growth?
- How are trends in personalized healthcare shaping the market outlook?
- Who are the major players, and what are their strategic initiatives?
- Which regions present the highest growth potential through 2032?
Leading companies in this market, such as Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, and Merck KGaA, are focusing on technological innovation and strategic partnerships to enhance product offerings. These firms are developing next-generation multiplex platforms with improved sensitivity and throughput. Collaborations with pharmaceutical companies and CROs are helping integrate multiplex assays into clinical trials and precision medicine programs. Moreover, companies are expanding into emerging markets and investing in digital tools for data interpretation to improve diagnostic workflows and gain a competitive edge.
Companies Covered in This Report:
- Meridian Bioscience
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- Bio-Techne
- DiaSorin S.p.A.
- BIOMÉRIEUX
- Quanterix
- Randox Laboratories Ltd.
- Merck KGaA
- Revvity
- F. Hoffmann-La Roche Ltd
- Sartorius AG
- Seegene Inc.
- BioGenex
- Miltenyi Biotec
By Product:
- Instruments
- Kits & Reagents
- Software & Services
- Nucleic Acid Multiplex Assays
- Protein Multiplex Assays
- Cell-Based Multiplex Assays
- Flow Cytometry
- Multiplex Bead-Based Assay
- Luminescence
- Multiplex Real-Time PCR
- Others
- Disease Diagnostics
- Research & Development
- Drug Discovery & Development
- Others
- Pharmaceutical & Biotech Companies
- Clinical Research Organizations (CROs)
- Academic Research Institutes
- Diagnostic and Reference Laboratories
- Others
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
199 Pages
- 1. Executive Summary
- 1.1. Global Multiplex Detection Immunoassay Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Product Adoption Analysis
- 3.2. Regulatory Landscape
- 3.3. Value Chain Analysis
- 3.4. Key Deals and Mergers
- 3.5. PESTLE Analysis
- 3.6. Porter’s Five Force Analysis
- 4. Price Analysis, 2025A
- 4.1. Key Highlights
- 4.2. Key Factors Impacting Product Prices
- 4.3. Pricing Analysis, By Product
- 4.4. Regional Prices and Product Preferences
- 5. Global Multiplex Detection Immunoassay Market Outlook
- 5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
- 5.2. Market Size (US$ Mn) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
- 5.3. Global Multiplex Detection Immunoassay Market Outlook: Product
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
- 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 5.3.3.1. Instruments
- 5.3.3.2. Kits & Reagents
- 5.3.3.3. Software & Services
- 5.3.4. Market Attractiveness Analysis: Product
- 5.4. Global Multiplex Detection Immunoassay Market Outlook: Technique
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis, By Technique, 2019-2024
- 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
- 5.4.3.1. Nucleic Acid Multiplex Assays
- 5.4.3.2. Protein Multiplex Assays
- 5.4.3.3. Cell-Based Multiplex Assays
- 5.4.4. Market Attractiveness Analysis: Technique
- 5.5. Global Multiplex Detection Immunoassay Market Outlook: Technology
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2024
- 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
- 5.5.3.1. Flow Cytometry
- 5.5.3.2. Multiplex Bead-Based Assay
- 5.5.3.3. Luminescence
- 5.5.3.4. Multiplex Real-Time PCR
- 5.5.3.5. Others
- 5.5.4. Market Attractiveness Analysis: Technology
- 5.6. Global Multiplex Detection Immunoassay Market Outlook: Application
- 5.6.1. Introduction / Key Findings
- 5.6.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
- 5.6.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 5.6.3.1. Disease Diagnostics
- 5.6.3.2. Research & Development
- 5.6.3.3. Drug Discovery & Development
- 5.6.3.4. Others
- 5.6.4. Market Attractiveness Analysis: Application
- 5.7. Global Multiplex Detection Immunoassay Market Outlook: End User
- 5.7.1. Introduction / Key Findings
- 5.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
- 5.7.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 5.7.3.1. Pharmaceutical & Biotech Companies
- 5.7.3.2. Clinical Research Organizations (CROs)
- 5.7.3.3. Academic Research Institutes
- 5.7.3.4. Diagnostic and Reference Laboratories
- 5.7.3.5. Others
- 5.7.4. Market Attractiveness Analysis: End User
- 6. Global Multiplex Detection Immunoassay Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
- 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
- 7. North America Multiplex Detection Immunoassay Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Technique
- 7.2.4. By Technology
- 7.2.5. By Application
- 7.2.6. By End User
- 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 7.4.1. Instruments
- 7.4.2. Kits & Reagents
- 7.4.3. Software & Services
- 7.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
- 7.5.1. Nucleic Acid Multiplex Assays
- 7.5.2. Protein Multiplex Assays
- 7.5.3. Cell-Based Multiplex Assays
- 7.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
- 7.6.1. Flow Cytometry
- 7.6.2. Multiplex Bead-Based Assay
- 7.6.3. Luminescence
- 7.6.4. Multiplex Real-Time PCR
- 7.6.5. Others
- 7.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 7.7.1. Disease Diagnostics
- 7.7.2. Research & Development
- 7.7.3. Drug Discovery & Development
- 7.7.4. Others
- 7.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 7.8.1. Pharmaceutical & Biotech Companies
- 7.8.2. Clinical Research Organizations (CROs)
- 7.8.3. Academic Research Institutes
- 7.8.4. Diagnostic and Reference Laboratories
- 7.8.5. Others
- 7.9. Market Attractiveness Analysis
- 8. Europe Multiplex Detection Immunoassay Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Technique
- 8.2.4. By Technology
- 8.2.5. By Application
- 8.2.6. By End User
- 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
- 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 8.4.1. Instruments
- 8.4.2. Kits & Reagents
- 8.4.3. Software & Services
- 8.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
- 8.5.1. Nucleic Acid Multiplex Assays
- 8.5.2. Protein Multiplex Assays
- 8.5.3. Cell-Based Multiplex Assays
- 8.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
- 8.6.1. Flow Cytometry
- 8.6.2. Multiplex Bead-Based Assay
- 8.6.3. Luminescence
- 8.6.4. Multiplex Real-Time PCR
- 8.6.5. Others
- 8.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 8.7.1. Disease Diagnostics
- 8.7.2. Research & Development
- 8.7.3. Drug Discovery & Development
- 8.7.4. Others
- 8.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 8.8.1. Pharmaceutical & Biotech Companies
- 8.8.2. Clinical Research Organizations (CROs)
- 8.8.3. Academic Research Institutes
- 8.8.4. Diagnostic and Reference Laboratories
- 8.8.5. Others
- 8.9. Market Attractiveness Analysis
- 9. East Asia Multiplex Detection Immunoassay Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Technique
- 9.2.4. By Technology
- 9.2.5. By Application
- 9.2.6. By End User
- 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 9.4.1. Instruments
- 9.4.2. Kits & Reagents
- 9.4.3. Software & Services
- 9.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
- 9.5.1. Nucleic Acid Multiplex Assays
- 9.5.2. Protein Multiplex Assays
- 9.5.3. Cell-Based Multiplex Assays
- 9.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
- 9.6.1. Flow Cytometry
- 9.6.2. Multiplex Bead-Based Assay
- 9.6.3. Luminescence
- 9.6.4. Multiplex Real-Time PCR
- 9.6.5. Others
- 9.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 9.7.1. Disease Diagnostics
- 9.7.2. Research & Development
- 9.7.3. Drug Discovery & Development
- 9.7.4. Others
- 9.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 9.8.1. Pharmaceutical & Biotech Companies
- 9.8.2. Clinical Research Organizations (CROs)
- 9.8.3. Academic Research Institutes
- 9.8.4. Diagnostic and Reference Laboratories
- 9.8.5. Others
- 9.9. Market Attractiveness Analysis
- 10. South Asia & Oceania Multiplex Detection Immunoassay Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Technique
- 10.2.4. By Technology
- 10.2.5. By Application
- 10.2.6. By End User
- 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
- 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 10.4.1. Instruments
- 10.4.2. Kits & Reagents
- 10.4.3. Software & Services
- 10.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
- 10.5.1. Nucleic Acid Multiplex Assays
- 10.5.2. Protein Multiplex Assays
- 10.5.3. Cell-Based Multiplex Assays
- 10.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
- 10.6.1. Flow Cytometry
- 10.6.2. Multiplex Bead-Based Assay
- 10.6.3. Luminescence
- 10.6.4. Multiplex Real-Time PCR
- 10.6.5. Others
- 10.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 10.7.1. Disease Diagnostics
- 10.7.2. Research & Development
- 10.7.3. Drug Discovery & Development
- 10.7.4. Others
- 10.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 10.8.1. Pharmaceutical & Biotech Companies
- 10.8.2. Clinical Research Organizations (CROs)
- 10.8.3. Academic Research Institutes
- 10.8.4. Diagnostic and Reference Laboratories
- 10.8.5. Others
- 10.9. Market Attractiveness Analysis
- 11. Latin America Multiplex Detection Immunoassay Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Technique
- 11.2.4. By Technology
- 11.2.5. By Application
- 11.2.6. By End User
- 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
- 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 11.4.1. Instruments
- 11.4.2. Kits & Reagents
- 11.4.3. Software & Services
- 11.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
- 11.5.1. Nucleic Acid Multiplex Assays
- 11.5.2. Protein Multiplex Assays
- 11.5.3. Cell-Based Multiplex Assays
- 11.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
- 11.6.1. Flow Cytometry
- 11.6.2. Multiplex Bead-Based Assay
- 11.6.3. Luminescence
- 11.6.4. Multiplex Real-Time PCR
- 11.6.5. Others
- 11.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 11.7.1. Disease Diagnostics
- 11.7.2. Research & Development
- 11.7.3. Drug Discovery & Development
- 11.7.4. Others
- 11.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 11.8.1. Pharmaceutical & Biotech Companies
- 11.8.2. Clinical Research Organizations (CROs)
- 11.8.3. Academic Research Institutes
- 11.8.4. Diagnostic and Reference Laboratories
- 11.8.5. Others
- 11.9. Market Attractiveness Analysis
- 12. Middle East & Africa Multiplex Detection Immunoassay Market Outlook
- 12.1. Key Highlights
- 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Product
- 12.2.3. By Technique
- 12.2.4. By Technology
- 12.2.5. By Application
- 12.2.6. By End User
- 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
- 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 12.4.1. Instruments
- 12.4.2. Kits & Reagents
- 12.4.3. Software & Services
- 12.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
- 12.5.1. Nucleic Acid Multiplex Assays
- 12.5.2. Protein Multiplex Assays
- 12.5.3. Cell-Based Multiplex Assays
- 12.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
- 12.6.1. Flow Cytometry
- 12.6.2. Multiplex Bead-Based Assay
- 12.6.3. Luminescence
- 12.6.4. Multiplex Real-Time PCR
- 12.6.5. Others
- 12.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 12.7.1. Disease Diagnostics
- 12.7.2. Research & Development
- 12.7.3. Drug Discovery & Development
- 12.7.4. Others
- 12.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 12.8.1. Pharmaceutical & Biotech Companies
- 12.8.2. Clinical Research Organizations (CROs)
- 12.8.3. Academic Research Institutes
- 12.8.4. Diagnostic and Reference Laboratories
- 12.8.5. Others
- 12.9. Market Attractiveness Analysis
- 13. Competition Landscape
- 13.1. Market Share Analysis, 2025
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Meridian Bioscience
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Product
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. Thermo Fisher Scientific Inc.
- 13.3.3. Bio-Rad Laboratories, Inc.
- 13.3.4. QIAGEN
- 13.3.5. Bio-Techne
- 13.3.6. DiaSorin S.p.A.
- 13.3.7. BIOMÉRIEUX
- 13.3.8. Quanterix
- 13.3.9. Randox Laboratories Ltd.
- 13.3.10. Merck KGaA
- 13.3.11. Revvity
- 13.3.12. F. Hoffmann-La Roche Ltd
- 13.3.13. Sartorius AG
- 13.3.14. Seegene Inc.
- 13.3.15. BioGenex
- 13.3.16. Miltenyi Biotec
- 13.3.17. SouthernBiotech
- 13.3.18. Healgen
- 13.3.19. Sepmag
- 13.3.20. Curiox Biosystems
- 13.3.21. MESO SCALE DIAGNOSTICS, LLC
- 13.3.22. Wuxi NEST Biotechnology Co.,Ltd
- 14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
